Filing Details
- Accession Number:
- 0001209191-12-042837
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-22 13:45:57
- Reporting Period:
- 2012-08-13
- Filing Date:
- 2012-08-22
- Accepted Time:
- 2012-08-22 13:45:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1003642 | Impax Laboratories Inc | IPXL | Pharmaceutical Preparations (2834) | 650403311 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1245365 | Nigel Fleming | C/O Impax Laboratories, Inc. 30831 Huntwood Avenue Hayward CA 94544 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-08-13 | 6,000 | $6.55 | 7,999 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-08-20 | 6,000 | $6.55 | 13,999 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-08-20 | 6,000 | $23.99 | 7,999 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-08-13 | 6,000 | $0.00 | 6,000 | $6.55 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-08-20 | 6,000 | $0.00 | 6,000 | $6.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 30,000 | 2019-05-20 | No | 4 | M | Direct | |
| 24,000 | 2019-05-20 | No | 4 | M | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- The option became exercisable in three equal annual installments beginning on May 20, 2010, which was the first anniversary of the date on which the option was granted.
Billionaire Hedge Funds
